Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CFLT Confluent	$24.16 -1.4%	$23.40	$17.79 ▼ $37.90	$8.22B	0.99	5.01 million shs	5.69 million shs
INMD InMode	$14.71 -3.1%	$14.40	$13.14 ▼ $19.85	$929.80M	1.95	1.21 million shs	971,126 shs
TMO Thermo Fisher Scientific	$435.02 +1.0%	$409.39	$385.46 ▼ $627.88	$164.16B	0.77	2.00 million shs	2.51 million shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CFLT Confluent	0.00%	-8.38%	-1.02%	+12.32%	-6.32%
INMD InMode	0.00%	-2.94%	+4.70%	-1.14%	-16.18%
TMO Thermo Fisher Scientific	0.00%	+1.58%	+4.86%	-0.66%	-18.97%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CFLT Confluent	2.6576 of 5 stars	3.4	2.0	0.0	0.0	2.8	2.5	0.6
INMD InMode	4.1271 of 5 stars	4.1	4.0	0.0	0.0	3.2	1.7	1.9
TMO Thermo Fisher Scientific	4.9925 of 5 stars	4.4	5.0	2.5	4.1	3.4	2.5	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CFLT Confluent	2.76	Moderate Buy	$30.19	24.94% Upside
INMD InMode	2.13	Hold	$18.54	26.05% Upside
TMO Thermo Fisher Scientific	2.80	Moderate Buy	$600.30	37.99% Upside

Current Analyst Ratings Breakdown

Latest CFLT, INMD, and TMO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/11/2025	CFLT Confluent	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$30.00 ➝ $32.00
7/11/2025	INMD InMode	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold	$15.00
7/11/2025	TMO Thermo Fisher Scientific	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sector Perform ➝ Sector Outperform	$590.00
7/8/2025	TMO Thermo Fisher Scientific	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$500.00 ➝ $460.00
7/8/2025	TMO Thermo Fisher Scientific	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$500.00 ➝ $480.00
6/24/2025	TMO Thermo Fisher Scientific	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$475.00 ➝ $450.00
5/21/2025	CFLT Confluent	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral
5/12/2025	CFLT Confluent	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$37.00 ➝ $25.00
5/1/2025	CFLT Confluent	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$42.00 ➝ $28.00
5/1/2025	CFLT Confluent	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$38.00 ➝ $32.00
5/1/2025	CFLT Confluent	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Outperform ➝ Market Outperform	$40.00 ➝ $36.00

(Data available from 7/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CFLT Confluent	$963.64M	8.53	N/A	N/A	$2.89 per share	8.36
INMD InMode	$394.82M	2.36	$1.82 per share	8.07	$10.12 per share	1.45
TMO Thermo Fisher Scientific	$42.88B	3.83	$30.04 per share	14.48	$129.54 per share	3.36

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CFLT Confluent	-$345.07M	-$0.98	N/A	N/A	N/A	-31.42%	-29.92%	-10.78%	7/30/2025 (Estimated)
INMD InMode	$181.27M	$2.33	6.31	8.08	N/A	44.79%	17.17%	15.20%	7/30/2025 (Estimated)
TMO Thermo Fisher Scientific	$6.34B	$17.05	25.51	17.02	2.31	15.19%	17.15%	8.47%	7/23/2025 (Estimated)

Latest CFLT, INMD, and TMO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	INMD InMode	$0.50	N/A	N/A	N/A	N/A	N/A
7/30/2025	Q2 2025	CFLT Confluent	$0.08	N/A	N/A	N/A	$278.32 million	N/A
7/23/2025	Q2 2025	TMO Thermo Fisher Scientific	$5.22	N/A	N/A	N/A	$10.68 billion	N/A
4/30/2025	Q1 2025	CFLT Confluent	$0.07	$0.08	+$0.01	-$0.20	$264.45 million	$271.12 million
4/28/2025	Q1 2025	INMD InMode	$0.45	$0.31	-$0.14	$0.26	$82.21 million	$77.87 million
4/23/2025	Q1 2025	TMO Thermo Fisher Scientific	$5.10	$5.15	+$0.05	$3.98	$10.23 billion	$10.36 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CFLT Confluent	N/A	N/A	N/A	N/A	N/A
INMD InMode	N/A	N/A	N/A	N/A	N/A
TMO Thermo Fisher Scientific	$1.72	0.40%	N/A	10.09%	8 Years

Latest CFLT, INMD, and TMO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/10/2025	TMO Thermo Fisher Scientific	quarterly	$0.43	0.4%	9/15/2025	9/15/2025	10/15/2025
5/21/2025	TMO Thermo Fisher Scientific	quarterly	$0.43	0.43%	6/13/2025	6/13/2025	7/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CFLT Confluent	1.07	4.42	4.42
INMD InMode	N/A	8.73	7.86
TMO Thermo Fisher Scientific	0.64	1.77	1.38

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CFLT Confluent	78.09%
INMD InMode	68.04%
TMO Thermo Fisher Scientific	89.23%

Insider Ownership

Company	Insider Ownership
CFLT Confluent	9.20%
INMD InMode	6.92%
TMO Thermo Fisher Scientific	0.33%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CFLT Confluent	3,060	340.39 million	309.07 million	Optionable
INMD InMode	480	63.21 million	58.84 million	Optionable
TMO Thermo Fisher Scientific	125,000	377.49 million	376.25 million	Optionable

CFLT, INMD, and TMO Headlines

Recent News About These Companies

Top Biotech Stocks To Keep An Eye On - July 13th

2 hours ago | marketbeat.com

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Arjuna Capital

5 hours ago | marketbeat.com

Eos Management L.P. Invests $4.72 Million in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 13 at 8:36 AM | marketbeat.com

TFR Capital LLC. Takes Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 13 at 7:37 AM | marketbeat.com

Pittenger & Anderson Inc. Sells 741 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

July 13 at 7:11 AM | marketbeat.com

Schechter Investment Advisors LLC Has $2.20 Million Stake in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 13 at 6:08 AM | marketbeat.com

New York State Common Retirement Fund Decreases Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

July 13 at 6:00 AM | marketbeat.com

Scotiabank Upgrades Thermo Fisher (TMO) to Outperform, Lowers PT

July 13 at 5:09 AM | insidermonkey.com

Scotiabank Upgrades Thermo Fisher (TMO) to Outperform, Lowers PT

July 13 at 4:27 AM | msn.com

TMO - Thermo Fisher Scientific Inc Executives - Morningstar

July 12 at 11:26 PM | morningstar.comM

Thermo Fisher Scientific Insider Trading Activity

July 12 at 6:25 PM | benzinga.com

Promising Biotech Stocks To Research - July 12th

July 12 at 12:13 PM | marketbeat.com

Platform Technology Partners Acquires 2,041 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

July 12 at 8:56 AM | marketbeat.com

Arizona State Retirement System Acquires 5,991 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

July 12 at 8:45 AM | marketbeat.com

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Penserra Capital Management LLC

July 12 at 4:28 AM | marketbeat.com

Scotiabank Upgrades Thermo Fisher Scientific (TMO)

July 12 at 3:23 AM | msn.com

Zacks Research Issues Optimistic Forecast for TMO Earnings

July 12 at 2:17 AM | americanbankingnews.com

Biotech Stocks To Watch Now - July 11th

July 11 at 1:43 PM | marketbeat.com

This Thermo Fisher Scientific Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

July 11 at 12:35 PM | benzinga.com

13 Analysts Assess Thermo Fisher Scientific: What You Need To Know

July 11 at 12:19 PM | benzinga.com

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Ownership Capital B.V.

July 11 at 8:41 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CFLT, INMD, and TMO Company Descriptions

Confluent NASDAQ:CFLT

$24.16 -0.34 (-1.39%)

Closing price 07/11/2025 04:00 PM Eastern

Extended Trading

$24.33 +0.17 (+0.70%)

As of 07/11/2025 07:58 PM Eastern

Confluent, Inc. operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software. It offers connectors for existing applications, and IT and cloud infrastructure; Apache Flink services that allows teams to create reusable data streams that can be delivered real-time; ksqlDB, a data-in-motion database that allows users to build data-in-motion applications using a few SQL statements; stream governance, a managed data governance suite that is designed for the intricacies of streaming data, which allows teams to accelerate data streaming initiatives without bypassing controls for risk management and regulatory compliance; and stream designer which builds streaming data pipelines visually. In addition, the company offers professional services comprising packaged and residency offerings; education offerings consisting of instructor-led and self-paced training and certification guidance, technical resources, and access to hands-on training and certification exams; and certification programs. It serves banking and financial services industries, as well as retail and e-commerce, manufacturing, automotive, communication service providers, gaming, public sector, insurance, and technology industries. The company was formerly known as Infinitem, Inc. and changed its name to Confluent, Inc. in September 2014. Confluent, Inc. was incorporated in 2014 and is headquartered in Mountain View, California.

InMode NASDAQ:INMD

$14.71 -0.47 (-3.10%)

Closing price 07/11/2025 04:00 PM Eastern

Extended Trading

$14.73 +0.02 (+0.11%)

As of 07/11/2025 07:29 PM Eastern

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Thermo Fisher Scientific NYSE:TMO

$435.02 +4.29 (+1.00%)

Closing price 07/11/2025 03:59 PM Eastern

Extended Trading

$432.73 -2.29 (-0.53%)

As of 07/11/2025 07:30 PM Eastern

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time